Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?

导出 OA

翻译打印收藏纠错

作者： Poul F,Høilund-Carlsen ^[1] ; Abass,Alavi ^[2] ; Rudolph J,Castellani ^[3] ; Rachael L,Neve ^[4] ; George,Perry ^[5] ; Mona-Elisabeth,Revheim ^[6] ; Jorge R,Barrio ^[7]

作者单位： Department of Nuclear Medicine, Odense University Hospital, 5000 Odense C, Denmark. ^[1] Research Unit of Clinical Physiology and Nuclear Medicine, Department of Clinical Research, University of Southern Denmark, 5230 Odense M, Denmark. ^[2] Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. ^[3] Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. ^[4] Gene Delivery Technology Core, Massachusetts General Hospital, Boston, MA 02114, USA. ^[5] Department of Neuroscience, Developmental and Regenerative Biology and Genetics of Neurodegeneration, University of Texas at San Antonio, San Antonio, TX 78249, USA. ^[6] The Intervention Centre, Division of Technology and Innovation, Oslo University Hospital, 0372 Oslo, Norway. ^[7] Institute of Clinical Medicine, University of Oslo, 0313 Oslo, Norway. ^[8] Department of Molecular and Medical Pharmacology, David Geffen UCLA School of Medicine, Los Angeles, LA 90095, USA. ^[9]

关键词 ARIA ATN Alzheimer’s disease CDR-SB MICD MMSE RCT amyloid-PET

主题词美国(United States);人类(Humans);阿尔茨海默病(Alzheimer Disease);冰盖(Ice Cover);促淀粉样变蛋白质类(Amyloidogenic Proteins);放射免疫疗法(Radioimmunotherapy)

DOI 10.3390/ijms25073892

PMID 38612701

发布时间 2024-04-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交